Hexagon Bio
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1490 Obrien Dr Ste E, Menlo Park, Califo...Website
www.hexagonbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Hexagon Bio
Hexagon Bio is a drug discovery company enabled by a novel understanding of natural product evolution. Hexagon's highly interdisciplinary platform uses data science, genomics, synthetic biology, and automation to discover potent, evolutionarily refined small molecules and their protein targets directly from fungal genomes. Hexagon develops these molecules into therapeutics to combat human disease.Explore more
Hexagon Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hexagon Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Hexagon Bio launches new products
Click to see if Hexagon Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Hexagon Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Hexagon Bio recently announced quarterly report
Check if Hexagon Bio has recently received funding, and reach out quickly before it becomes old news!
Hexagon Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Hexagon Bio
Funding: Get notified immidiatlly once Hexagon Bio has new funding data
Recommended Actions
Find VP level buyers at Hexagon Bio
Find 3 more new buyers
Compare Similar Companies to Hexagon Bio
Compare insights from companies similar to Hexagon Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hexagon Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hexagon Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hexagon Bio.
Hexagon Bio financials insights
Gather financial insights about Hexagon Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$61M
2022
Series A
$47M
2023
Series B
$77.3M
Hexagon Bio Tech Stack
A closer look at the technologies used by Hexagon Bio
See more technologies
Most Recent Scoops
Person-Based
Product Development, Clinical Operations
Person-Based
Person-Based
Events, Pharmaceuticals
Hiring Plans
Hexagon Bio has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Python with an increased focus that include Chromatography, Bioanalysis, Mass Spectrometry, Sample Preparation, Pharmaceutical Sciences, Pharming, and Biotechnology.
Hiring Plans
Open Position
Hexagon Bio News & Media
Hexagon Bio Appoints Yujiro Hata to Board of Directors
Hexagon Bio announced today the appointment of Yujiro Hata, President and CEO of IDEAYA Biosciences, to its Board of Directors.Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules
MENLO PARK, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised a $77.3 million Series B financing and made key appointments to its leadership team. Existing investors, including The Column Group, Two Sigma Ventures, 8VC, and Nextech, participated in the Series B round, joined by additional new investors, including Canada Pension Plan Investment Board (CPP InvHexagon Bio Raises a $47 Million Series A to Develop Fungi-Based Medicine
California-based Hexagon Bio has closed a $47 million Series A funding round led by The Column Group, with participation from 8VC and Two Sigma Ventures.Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes
MENLO PARK, Calif.--(BUSINESS WIRE)--Hexagon Bio, a biopharmaceutical company mining microbial genomes to discover new medicines, has raised $61M to advance preclinical programs.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Hexagon Bio
Sign Up For FreeTo access detailed company insights
Hexagon Bio is a drug discovery company enabled by a novel understanding of natural product evolution. Hexagon's highly interdisciplinary platform uses data science, genomics, synthetic biology, and automation to discover potent, evolutionarily refined small molecules and their protein targets directly from fungal genomes. Hexagon develops these mo... Read More
